An appraisal of tolerance in liver transplantation

American Journal of Transplantation

Volumn 6, Issue 8, 2006, Pages 1774-1780

  Lerut, J ^a   Sanchez Fueyo, A ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Graft acceptance; Immunosuppression; Liver transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; STEROID; TACROLIMUS;

ACCURACY; ACUTE GRAFT REJECTION; ASSAY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; DRUG WITHDRAWAL; GRAFT RECIPIENT; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME; VALIDATION PROCESS;

ANIMALS; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION;

EID: 33745804056     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01396.x     Document Type: Short Survey

References (31)

1. Markus BH, Duquesnoy RJ, Gordon RD et al. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation 1988; 46: 372-377.
2. Calne R, Davies H. Organ graft tolerance: The liver effect. Lancet 1994; 343: 67-68.
3. Lerut JP. Avoiding steroids in solid organ transplantation. Transpl Int 2003; 16: 213-224.
4. Wiesner RH, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Lake JR. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl 2005; 11: 750-759.
5. Starzl TE, Murase N, Abu-Elmagd K et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003; 361: 1502-1510.
6. Demetris AJ, Qian S, Sun H et al. Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am J Pathol 1991; 138: 609-618.
7. McVicar JP, Kowdley KV, Bacchi CE et al. The natural history of untreated focal allograft rejection in liver transplant recipients. Liver Transpl Surg 1996; 2: 154-160.
8. Cobbold S, Waldmann H. Infectious tolerance. Curr Opin Immunol 1998; 10: 518-524.
9. Calne RY. Prope tolerance: The future of organ transplantation-from the laboratory to the clinic. Transplantation 2004; 77: 930-932.
10. Starzl TE, Demetris AJ, Trucco M et al. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance. Hepatology 1993; 17: 1127-1152.
11. Manez R, Kusne S, Linden P et al. Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation. Transplantation 1994; 57: 149-151.
12. Massarollo PC, Mies S, Abdala E, Leitao RM, Raia S. Immunosuppression withdrawal for treatment of severe infections in liver transplantation. Transplant Proc 1998; 30: 1472-1474.
13. Hurwitz M, Desai DM, Cox KL, Berquist WE, Esquivel CO, Millan MT. Complete immunosuppressive withdrawal as a uniform approach to post-transplant lymphoproliferative disease in pediatric liver transplantation. Pediatr Transplant 2004; 8: 267-272.
14. Devlin J, Doherty D, Thomson L et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 1998; 27: 926-933.
15. Mazariegos GV, Reyes J, Marino IR et al. Weaning of immunosuppression in liver transplant recipients. Transplantation 1997;63: 243-249.
16. Pons JA, Yelamos J, Ramirez P et al. Endothelial cell chimerism does not influence allograft tolerance in liver transplant patients after withdrawal of immunosuppression. Transplantation 2003; 75: 1045-1047.
17. Eason JD, Cohen AJ, Nair S, Alcantera T, Loss GE. Tolerance: Is it worth the risk? Transplantation 2005; 79: 1157-1159.
18. Takatsuki M, Uemoto S, Inomata Y et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001; 72: 449-454.
19. Tryphonopoulos P, Tzakis AG, Weppler D et al. The role of donor bone marrow infusions in withdrawal of immunosuppression in adult liver allotransplantation. Am J Transplant 2005; 5: 608-613.
20. Tisone G, Orlando G, Palmieri G et al. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol 2006; 44: 702-709.
21. Mazariegos GV, Zahorchak AF, Reyes J et al. Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant 2003; 3: 689-696.
22. Shodell M, Siegal FP. Circulating, interferon-producing plasmacytoid dendritic cells decline during human ageing. Scand J Immunol 2002; 56: 518-521.
23. Hackstein H, Renner FC, Bohnert A et al. Dendritic cell deficiency in the blood of kidney transplant patients on long-term immunosuppression: Results of a prospective matched-cohort study. Am J Transplant 2005; 5: 2945-2953.
24. Girlanda R, Rela M, Williams R, O'Grady JG, Heaton ND. Long-term outcome of immunosuppression withdrawal after liver transplantation. Transplant Proc 2005; 37: 1708-1709.
25. Oike F, Yokoi A, Nishimura E et al. Complete withdrawal of immunosuppression in living donor liver transplantation. Transplant Proc 2002; 34: 1521.
26. Takatsuki M, Uemoto S, Inomata Y et al. Analysis of alloreactivity and intragraft cytokine profiles in living donor liver transplant recipients with graft acceptance. Transpl Immunol 2001; 8: 279-286.
27. Li Y, Koshiba T, Yoshizawa A et al. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004; 4: 2118-2125.
28. Ueda M, Koshiba T, Li Y, Pirenne J, Haga H, Tanaka K. Requirement of protocol biopsy before and after complete cessation of immunosuppression following living-donor liver transplantation (Abstract). Liver Transpl 2006; 11: Abstr 122.
29. Sebagh M, Rifai K, Feray C et al. All liver recipients benefit from the protocol 10-year liver biopsies. Hepatology 2003; 37: 1293-1301.
30. Anand AC, Hubscher SG, Gunson BK, McMaster P, Neuberger JM. Timing, significance, and prognosis of late acute liver allograft rejection. Transplantation 1995; 60: 1098-1103.
31. Pappo O, Ramos H, Starzl TE, Fung JJ, Demetris AJ. Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol 1995; 19: 192-206.